TCS FOR SWING TRADETCS Swing Trade Idea
Timeframe: Weekly
Observation:
TCS has entered a strong demand zone on the weekly chart, indicating a potential reversal or continuation of an upward trend. The price action suggests that buyers are actively defending this zone, providing a solid risk-to-reward opportunity.
Analysis:
Demand Zone: Clearly visible on the weekly timeframe, supported by historical price reactions.
Volume Profile: Higher buying volumes observed near the demand zone, adding conviction.
Risk-Reward Setup: Place a stop-loss slightly below the demand zone with targets at key resistance levels (based on Fibonacci or previous highs).
Disclaimer: This is for educational purposes and not financial advice. Please do your due diligence before trading.
Community ideas
HCLTECH |Upcoming Trade set up|Hey Family, there is a one more stock Which is showing a great opportunity.
Key Points:-
* Formation of Ascending Triangle Pattern in Daily TF.
* From Sep 2024 to Nov 2024 Tested & Moving Near Resistance Many times.
* It's Near resistance Zone and trying to Sustain Near Resistance Zone with good volume good closing required.
* Volume Accumulation (Volume is Rising).
What is your view please comment it down and also boost the idea this help to motivate us. We are Certified. All views shared on this channel are my personal opinion and is shared for educational purpose and should not be considered advise of any nature.
Long trade in BSE Multiple VCP contractions visible on hourly timeframe. Relative strength (stan weinstein) is also rising. This presents a low risk entry in the stock.
Aggressive traders can enter right away with SL of 4650 (end of day closing)
Conservative traders can enter with SL of 4480 (end of day closing)
For those looking for more conformation, can wait till breakout above 4900 with good volumes.
Disclaimer: This is not a recommendation, do your own research before taking positions.
Classic Double Correction PatternThis is a classic example of Double correction (Double three) in HDFCLIFE.
Marked in the first box, we can see Flat Correction where wave B is retraced to the 81% level. We are fulfilling the minimum requirement (61.8%) of wave B. Here in wave C, we see three waves. This is the first hint of an upcoming complex correction. The whole wave is marked as W here.
In the second box, there is a perfect Zig-zag pattern. Wave B is retraced to 50% here. Also, we can see three waves in wave C, which gives us wave Y.
These two waves are connected by wave X which is retraced to 111%.
This is the best example of Double correction.
This analysis is for educational purposes only.
This analysis is based on Elliott Wave theory and Fibonacci analysis.
Hammer Candlestick Pattern on support zone in Bajaj FinanceHello Everyone, i hope you all will be doing good in your life and your trading as well. Today i have brought a short term swing Trading Idea in Bajaj finance. Stock have formed hammer candlestick pattern on perfect support zone, Bajaj finance stock is trading inside the triangle pattern and chances are very high that we can see this towards upper resistance of triangle pattern which i plotted on chart above. Overall i feel stock should rise from here and no double over the period if we can see most awaited breakout in Bajaj Finance.
Technically stock is looking good for swing trade, and also if anybody wants to think for long term can take entry as chances are high that this time after spending some time we will see finally breakout in it. Please follow strictly stop loss which i mention above on chart, it will save you if something goes against to our analysis.
Disclaimer:- Please always do your own analysis or consult with your financial advisor before taking any kind of trades.
Dear traders, If you like my work then do not forget to hit like and follow me, and guy's let me know what do you think about this idea in comment box, i would be love to reply all of you guy's.
Thankyou.
BAJFINANCE - Ready To Bounce from LongTerm Support AreaThe chart shows Bajaj Finance Ltd. forming a 3-year long ascending triangle pattern, a bullish continuation setup.
Key observations:
1.Consistent higher lows indicate strong buyer support along the long-term uptrend line.
2.A bullish hammer candlestick suggests a potential reversal near the support level.
3.The stock has also formed a triple bottom near long term support making a confluence area.
Dhani Services Ltd. Based on Rectangle Pattern Breakout
1. Pattern Analysis
- Rectangle Pattern:
- Timeframe: 2 Years
- Description: The stock has been consolidating within a rectangle pattern, with a well-defined resistance at ₹75 and support at ₹40. This prolonged sideways movement indicates accumulation and a potential buildup for a significant move.
- The breakout above ₹75 marks the end of the consolidation phase and the start of an upward trend, confirming a bullish breakout.
2. Volume Analysis
- Volume Behavior:
- During the consolidation phase, volume remained low, which is typical for a rectangle pattern.
- A notable volume spike during the breakout, as seen recently, signifies increased market participation and validates the breakout.
3. Price Action Analysis
- Resistance Levels:
- ₹75: The previous resistance and breakout level.
- ₹90–₹100: Immediate target zone based on historical price action.
- Support Levels:
- ₹60: Potential retest zone after the breakout.
- ₹40: The lower boundary of the rectangle, serving as the final support.
- Candlestick Behavior:
- The breakout was marked by a strong bullish candlestick with a close near its high, indicating momentum.
- Recent higher highs and higher lows further confirm bullish price action.
4. Validation of Bullish Signal
- The breakout above ₹75 is supported by a clear volume spike, showing increased demand.
- The long consolidation period adds reliability to the breakout, as prolonged patterns tend to yield stronger moves.
5. Target Setting
- Rectangle Pattern Target:
- Height of the rectangle = ₹75 - ₹40 = ₹35.
- Target = ₹75 + ₹35 = ₹110.
- Incremental Targets:
- Target 1: ₹90 (+20% from ₹75).
- Target 2: ₹110 (+46% from ₹75).
6. Entry and Stop Loss
- Entry Levels:
- Primary Entry: Above ₹75 after the breakout.
- Pullback Entry: Near ₹60 if the stock retests the breakout level.
- Stop Loss:
- Place a stop loss at ₹60, below the potential pullback zone.
7. Trade Setup Summary
- Entry Levels:
- Above ₹75 for momentum traders.
- Near ₹60 for a pullback entry.
- Targets:
- Target 1: ₹90 (+20%).
- Target 2: ₹110 (+46%).
- Stop Loss: ₹60.
8. Final Notes
Dhani Services Ltd. has successfully broken out of a 2-year rectangle pattern, with strong volume confirming the breakout. The long-term consolidation suggests that the breakout has significant potential to drive the stock higher, making it an attractive opportunity for traders. Close monitoring of price action around ₹75 and ₹60 is recommended for entry and to manage risk effectively.
SRM Trade ideaThere was dal in price after IPO. Then new uptrend started for some time it consolidated and moved on sideways trend. Now be new uptrend is likely to unfold as there are clear increased volumes and inspite of DOJI candle the volume increase in last trading session.
So FVG created ; price may retrace till 280-290
We can buy some quantity at CMP 314; add some at filling of FVG.
THE TARGETS CAN BE upto 340,360,400
Based on Fibonacci extensions.
Di your own analysis also and watch the price action. Comment about it.
HCLTECH shortHCL Technologies (HCLTECH) is exhibiting signs of a potential bearish trend reversal. A clear bearish divergence has formed between price and the Relative Strength Index (RSI), indicating weakening bullish momentum.
Key Observations:
1. Bearish Divergence:
Price has made higher highs, but the RSI has formed lower highs.
This divergence suggests a potential bearish trend reversal.
2. Volume Weakness:
Volume has been declining as the price has increased, indicating waning buying interest.
3. Broken RSI Support:
The stock has broken below a key weekly RSI support level and has retested it, confirming the bearish bias.
Trading Strategy:
Short Entry: Consider shorting HCLTECH around the current price level or a slight pullback to the broken RSI support level.
Stop-Loss: Place a stop-loss order at 1900 on a closing basis to limit potential losses.
Profit Targets:
Target 1: 1700
Target 2: 1540
Target 3: 1420
Is this stock potential? How can we trade? HDFC AMC All of the major index and stocks are trading in bearish structure. Market is potentially discounted and we can look for some buy opportunities.
Looking at HDFC AMC stocks, it is still trading in Bullish structure. For any buy setup we would wait for a Change of structure on lower timeframe , mostly on 15 mins.
Look for MSs on 15min and then we can target the daily recent high as future targets.
Trade safe. This is just for educational purposes.
SUNPHARMA - BREAKOUT RETEST or END of 5th?SUNPHARMA - CMP 1747
It appears that a 5 wave impulse from Covid lows (312) has ended at 1960
Primary and internal counts are marked in the chart
If it is too early to predict/expect a larger retracement of the entire move, lets take one step at a time and look for the price action from May'23 lows.. The 5 wave impulse from 922 to 1960. Even here, the 5 waves are complete and the price is falling/retracing.
Chart is attached here for reference
If we expect a minimum of 50% retracement of this 5 wave impulse, then we are looking at 1440 levels
Worst case, if you look at breakout retest (for those with bullish bias), then a dip down to 1640 cant be ruled out
Price is trading below the cloud and Super trend on Daily TF
Price is trading below all key EMAs.. and 200 EMA is next, placed at 1650 levels.
Definitely not a place to go long..
Daily close above 1800 would be the invalidation level
I am not a SEBI registered Analyst. Views are personal and for educational purpose only. Please consult your Financial Advisor for any investment decisions.
BAJAJ Housing Finance Descending TriangleThird time touched the support trendline
- opens above this trend line stock might go up
- opens below this candle or trend line stock might go down
morning star formed in Descending Triangle bottom which might track the stock to downside
I don't recommend & taking trade based on this idea.
consult your SEBI registered adviser to Know the market risk before trade.
in.tradingview.com/pricing/?share_your_love=johnbritto2088
ESCORTS
The stock is currently approaching its dual support placed between 3340 and 3100 (61.8% FR level & 100 Week EMA).
The Weekly RSI is also coming to its Oversold level.
Past price corrections in this on-going up-move has bottomed out at the 61.8% FR and 100 Week EMA.
The Weekly MACD crossing above its Trigger line would confirm resumption of the up-move.
NIFTY50-pain in short term & reward in long term ....NIFTY50 : 23572.30
NIFTY is in Primary Bull cycle phase (on weekly charts) and in middle of Wave -3, which should take the NIFTY at levels of 33k-43K & finally 55K in next 2 years’ time frame .
On immediate basis (on daily chart basis) chart structure suggest it has entered Intermediate level wave -4 correction. Nifty at its crucial support of 200 Simple Moving Average, and on the weak footing. If nifty doesn’t hold these levels, it will open the downside till 20420 levels . Chart structure suggest that still downside risk is open.
The support levels are listed below
200 SMA placed @23542
S1- 22557; S2-21675; S3- 20420
Currently Nifty is in price correction mode which suggest it to last till Jan 25, and if followed by time corrections, than Fibonacci level suggest the these correction may last till another 2 quarters (Q1 FY25).
DCAL - Potential C&H -Back in Profits. Buy above 215.DCAL is forming Cup & Handle Pattern.
One can enter above 215 with target of 255/400/600/780, with Stop Loss of 171.
Here's a summary of the key points for investors from Dishman Carbogen Amcis Limited's (DCAL) presentation for Q2 FY25:
Financial Highlights
1. Revenue Growth: Net revenue for Q2 FY25 increased by 34.5% YoY to ₹7,890 million, driven by a boost in commercial sales, particularly in the CRAMS (Contract Research and Manufacturing Services) segment in Switzerland and India.
2. Profitability: EBITDA rose significantly to ₹1,485 million with a margin increase from 10.8% in Q2 FY24 to 18.8% in Q2 FY25, due to higher volumes and improved operating margins.
3. Cash Profit: Cash profit for Q2 FY25 stood at ₹1,055 million, almost doubling YoY.
4. Net Debt: The company reported a net debt of CHF 173 million as of September 2024.
5. Capex: H1 FY25 capital expenditure reached approximately USD 15.9 million.
Operational Highlights
1. Revenue Mix:
- CRAMS: Major contributor with 84% of total revenue. Sales grew 51.7% YoY, fueled by increased commercial sales.
- NCE APIs & Intermediates: 6.2% share, with a 36.9% increase in revenue due to growth at the Bavla site in India.
- Cholesterol & Vitamin D Analogues: Decline in sales by 35.7% due to lower margin realization in Cholesterol SF.
- Quats & Generics: Decline due to reduced demand in the agrochemical sector.
2. Capacity Utilization: Focused on improving capacity utilization by targeting small to mid-sized global biotech companies and expanding in new geographies.
Strategic Insights
1. Global Presence: Operations span Switzerland, the UK, France, Netherlands, India, and China, with 28 R&D labs and multi-purpose facilities.
2. Oncology Focus: Oncology, a high-growth therapeutic area, is a priority, with several late-phase oncology molecules in the pipeline.
3. HIPO Facility: The Bavla site in India houses Asia's largest high-potency API (HIPO) facility, positioning DCAL well for growth in oncology.
Industry Overview
- Specialty Medicines Growth: Specialty medicines, which include high-potency oncology drugs, are projected to grow significantly, with an expected 43% share in global pharma spending by 2028.
- Oncology Market: Oncology is projected to grow at a CAGR of 14-17% through 2028, driven by new treatments and demand for potent drugs.
Investment Considerations
2. 1. Strong Revenue and Margin Growth: Consistent revenue growth with enhanced EBITDA margins, indicating improved operational efficiency.
2. Global Expansion & Diversification: Expanding into new geographies and targeting small/mid-size biotech clients mitigates risk and enhances revenue stability.
3. Oncology Focus and HIPO Facility: The HIPO capabilities in India align with the high-growth oncology sector, suggesting long-term growth potential in specialty pharma.
